Unraveling a Centuries-Old Mystery
By Dale Kiefer
Challenging Popular Assumptions About Influenza
Hope-Simpson questioned other beliefs about the nature of influenza. “Epidemics of influenza often occur contemporaneously at the same latitude, even in localities widely separated by longitude,” he noted.8 But if outbreaks occur simultaneously in widely separated areas, how can person-to-person transmission be responsible?
Much has been made of the potential dangers of quickly transmitted infection, due to modern modes of transportation. However, through careful examination of ancient records, Hope-Simpson showed that virtually simultaneous outbreaks occurred in England long before the advent of modern roads, let alone continent-spanning jet-liners. This challenged the fundamental assumption that influenza is transmitted in a chain from one patient to another. Could it be that the flu virus lies dormant in a range of potential hosts, until some “seasonal stimulus” promotes its infectivity among these unwitting carriers?
Back in California, Dr. Cannell could not help but wonder whether vitamin D played a role in his patients’ evident immunity to the flu. He knew several things that Hope-Simpson did not. For one, scientists now know that influenza infection prompts white blood cells known as macrophages to release immune system chemicals called cytokines and chemokines, which promote inflammation. Furthermore, scientists now know that the virus responsible for 1918’s devastating global influenza pandemic was especially effective in stimulating the release of cytokines by macrophages.10 In fact, the severity of the resulting illness is believed to be proportional to a flu virus’s ability to evoke cytokine production. In bird flu, for instance, this response can be overwhelming, resulting in death.11,12 Dr. Cannell also knew that research has recently shown that vitamin D modulates macrophages’ production of chemokines and cytokines, in effect preventing them from overreacting to infectious stimuli and causing serious manifestations of viral infection.13,14
Vitamin D’s Role in Bolstering Immunity
Nor did Hope-Simpson have knowledge of another recently reported phenomenon. In the past few years, several independent researchers have shown that vitamin D significantly enhances the genetic expression of antimicrobial peptides in human monocytes (precursors to macrophages), neutrophils, and other immune system cells.15,16 These antimicrobial proteins help to destroy invading infectious microbes. With their broad-spectrum activity, they are capable of killing everything from bacteria to viruses. They have been shown to be an important part of the respiratory tract’s defense against invaders, and likewise show promise in fighting the influenza virus.17-19
For Dr. Cannell, these various clues led to one inescapable conclusion: vitamin D—which is produced when the skin is exposed to summer sunlight, and which, conversely, declines in winter—plays a critical role in our vulnerability to influenza infection. In fact, vitamin D must surely be Hope-Simpson’s mysterious “seasonal stimulus.” Dr. Cannell consulted a number of leading vitamin D researchers, all of whom agreed with his conclusions. They include researchers from such venerable institutions as the National Institutes of Health and the Harvard School of Public Health. One of these scientists, Dr. Michael F. Holick, has been studying vitamin D for three decades.1,7,20
In an interview with Life Extension, Dr. Holick alluded to the special relationship between vitamin D and the body’s primary immune system defenders, the macrophages. “What intrigues me the most,” Dr. Holick noted, “is that we’ve always known that macrophages activate vitamin D.” The form of vitamin D generated through the skin’s interaction with ultraviolet B radiation (from sunshine or artificial sources) is a pre-hormone. It must be converted in the body to its active hormone form, called 1,25-dihydroxyvitamin D3. An intermediary form, known as 25-hydroxyvitamin D, is the major circulating form of vitamin D, and is measured to determine vitamin D status.20
Vitamin D’s Far-Ranging Effects on Disease Prevention
Most of this activation of vitamin D occurs in the liver and kidneys. However, the fact that macrophages facilitate the conversion of circulating vitamin D to its active form,20 and that activated vitamin D in turn regulates the activity of macrophages, suggests an important relationship between the two.
Dr. Holick notes that vitamin D receptors have been identified in virtually every cell in the body. “It’s one of the earliest vitamins,” he says. “It was made by phytoplankton (microscopic aquatic plants such as algae) 750 million years ago.” He believes that vitamin D plays an important role in many aspects of health. “If you live at higher latitudes where less vitamin D is available from sunshine, you’re more likely to suffer from diabetes, multiple sclerosis, and colon, breast, prostate, and pancreatic cancers,” he says. “Even hypertension is associated with latitude. Patients exposed to sunlight increase their vitamin D levels, and their blood pressure comes down.”
Dr. Holick has published numerous papers detailing the relationship between inadequate vitamin D levels and increased risk of diseases ranging from osteoporosis and arthritis to cardiovascular disease and cancers.21,22 “Activated vitamin D is one of the most potent inhibitors of cell growth,” he notes, a fact that may explain its importance in cancer prevention. “I don’t see any downside to taking pharmaceutical levels of vitamin D to fight prostate cancer,” he adds.
The Importance of Vitamin D Supplements
The bottom line is that far too many people are deficient in vitamin D,22,23 especially the elderly.24 Unfortunately, by following well-intentioned advice to minimize their exposure to the sun, aging adults may greatly diminish their ability to manufacture optimal levels of vitamin D, particularly compared to young people. This could put them at increased risk of contracting the flu.
Although Dr. Holick serves on the board responsible for amending existing government recommendations for vitamin D intake, he thinks it will be at least another four years before the government publishes new recommendations aimed at increasing vitamin D intake to adequate levels. According to Dr. Holick, there is simply too much data being generated too quickly, by researchers around the world, for committee members to evaluate it any faster.
Nevertheless, he strongly advises aging adults to begin increasing their supplemental intake of vitamin D now, especially in winter, when sunlight exposure at higher latitudes is insufficient to produce adequate vitamin D levels naturally. “Most people should supplement with vitamin D,” says Dr. Holick. “It’s perfectly safe to take, and is likely to have a benefit for all aspects of health.”
Dr. Holick anticipates that if enough people get the message, we are likely to see a noticeable drop in everything from cancer cases to flu outbreaks. “It would be quite amazing,” he says. “It might very well markedly decrease a person’s risk.” Dr. Holick himself takes 1000 IU of vitamin D every day.
Dr. Cannell’s approach to vitamin D for disease prevention is even more aggressive. He and his family members take 5000 IU of supplemental vitamin D daily during the winter months. “The implications are breathtaking,” says Dr. Cannell. “The best thing may be not to stock up on antiviral drugs, but to get some sunshine. Should you go into the flu season vitamin D deficient? No. It’s a widespread problem, and it should be addressed.”
The intriguing theory that vitamin D may help prevent or arrest viral respiratory infections has tremendous potential in helping million of people avert these potentially deadly outbreaks. To date, however, no interventional studies in humans have been conducted. Such trials are sorely needed to assess vitamin D’s efficacy in preventing or treating influenza.
In the meantime, however, all health-conscious people would be well advised to optimize their daily intake of vitamin D, particularly during the winter months. This low-cost dietary supplement may just be the best possible medicine for guarding against the flu virus and bolstering your protection against a host of age-related afflictions.
1. Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006 Dec;134(6):1129-40.
2. Reid AH, Taubenberger JK. The origin of the 1918 pandemic influenza virus: a continuing enigma. J Gen Virol. 2003 Sep;84(Pt 9):2285-92.
3. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003 Jan 8;289(2):179-86.
4. Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V. Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab. 2002 May;87(5):2024-32.
5. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in health care settings. Clin Infect Dis. 2003 Oct 15;37(8):1094-101.
6. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S-88S.
7. Available at: http://www.medicalnewstoday.com/medicalnews.php?newsid=51913. Accessed November 3, 2006.
8. Hope-Simpson RE. The role of season in the epidemiology of influenza. J Hyg (Lond). 1981 Feb;86(1):35-47.
9. Shek LP, Lee BW. Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatr Respir Rev. 2003 Jun;4(2):105-11.
10. Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature. 2004 Oct 7;431(7009):703-7.
11. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res. 2005;6135.
12. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005 Sep 29;353(13):1374-85.
13. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol Cell Endocrinol. 2004 Feb 27;215(1-2):31-8.
14. Helming L, Bose J, Ehrchen J, et al. 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood. 2005 Dec 15;106(13):4351-8.
15. Wang TT, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004 Sep 1;173(5):2909-12.
16. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006 Mar 24;311(5768):1770-3.
17. Reddy KV, Yedery RD, Aranha C. Antimicrobial peptides: premises and promises. Int J Antimicrob Agents. 2004 Dec;24(6):536-47.
18. Hiemstra PS, Fernie-King BA, McMichael J, Lachmann PJ, Sallenave JM. Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeutics. Curr Pharm Des. 2004;10(23):2891-905.
19. Laube DM, Yim S, Ryan LK, Kisich KO, Diamond G. Antimicrobial peptides in the airway. Curr Top Microbiol Immunol. 2006;306:153-82.
20. Holick MF. Defects in the synthesis and metabolism of vitamin D. Exp Clin Endocrinol Diabetes. 1995;103(4):219-27.
21. Holick MF. Vitamin D: A millenium perspective. J Cell Biochem. 2003 Feb 1;88(2):296-307.
22. Zipitis CS, Markides GA, Swann IL. Vitamin D deficiency: prevention or treatment? Arch Dis Child. 2006 Aug 31.
23. Holick MF. The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep. 2006 Sep;4(3):96-102.
24. Gennari C. Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr. 2001 Apr;4(2B):547-59.
25. Available at: http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0265.shtml. Accessed November 6, 2006.
26. Meletis CD. Vitamin D. Cancer prevention and other new uses. Life Extension. March, 2006:50-58.
27. Holick MF. Vitamin D deficiency: what a pain it is. Mayo Clin Proc. 2003 Dec;78(12):1457-9.
28. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999 May;69(5):842-56.
29. Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001 Feb;73(2):288-94 .
30. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003 Jan;77(1):204-10
31. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30:771-7.
32. Gloth FM 3d, Gundberg CM, Hollis BW, Haddad JG Jr, Tobin JD. Vitamin D deficiency in homebound elderly persons. JAMA. 1995;274:1683-6.